British firm partners with Celgene, Innate and Juno following Q1 revenue hike
British firm snaps up Surrey company that has unlicensed drugs in oncology and haematology
LCZ696 granted a Promising Innovative Medicine designation following good results
Companies rack up single and double digit year-on-year growth
The ABPI’s Dr Virginia Acha answers your questions about how companies can prepare for new legislation on conducting multi-state clinical trials...